Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;14(11):e70984.
doi: 10.1002/cam4.70984.

Incidence, Risk and Trends of Multiple Primary Cancers in Patients With Colorectal Cancer: Evidence From the South Australian Cancer Registry

Affiliations

Incidence, Risk and Trends of Multiple Primary Cancers in Patients With Colorectal Cancer: Evidence From the South Australian Cancer Registry

Mulugeta Melku et al. Cancer Med. 2025 Jun.

Abstract

Background: Colorectal cancer (CRC) is the fourth most diagnosed cancer in Australia. With advancements in treatment and an increase in survival rates, CRC survivors face an elevated risk of developing multiple primary cancers (MPCs), presenting a clinical challenge. Therefore, this study aimed to estimate the incidence, trend and risk of MPCs after a diagnosis of CRC in the South Australian population.

Methods: This study analysed South Australian Cancer Registry data on individuals diagnosed with CRC as their first cancer from 1982 to 2017. The incidence of MPCs was assessed using cumulative incidence functions, and age-standardised rates were estimated. Poisson regression was used to determine the risk, and standardised incidence ratios (SIR) and absolute excess risks (AER) were estimated. Trends over time were analysed using Joinpoint regression.

Results: The study included 26,729 CRC survivors. Of the cohort, 15% (3917) developed 4453 MPCs, with 96% diagnosed six or more months after index CRC. The cumulative incidence of MPCs was 22.5% (95% CI: 21.6-23.4). The median follow-up time until MPC diagnosis was 6.4 years. Common MPCs included prostate (18.9%), subsequent CRC (13.1%), lung (10.8%), haematological (10.2%) and breast (8.0%) cancers. The overall risk of MPCs was higher in CRC survivors (SIR: 1.12, 95% CI: 1.09-1.16; AER: 22.6 per 10,000) compared to the incidence in the general South Australian population. The incidence of MPCs has increased over time (annual percentage change = 1.95, 95% CI: 1.33-2.51).

Conclusions: CRC survivors are at increased risk of subsequent cancers, highlighting the need for targeted surveillance, particularly for prostate, lung, breast and blood cancers, for early detection and treatment.

Keywords: colorectal cancer survivors; incidence; multiple primary cancer; risk; trend.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Common types of multiple primary cancers by sex in individuals diagnosed with colorectal cancer between 1982 and 2017.
FIGURE 2
FIGURE 2
Trends of multiple primary cancers in individuals diagnosed with colorectal cancer in South Australia between 1990 and 2017. (A) Presented APC of MPC trend in both sexes combined, including all site cancers; (B) Presented APC of MPC trend in males excluding male breast cancer; (C) Presented APC of MPC trend in females.

Similar articles

Cited by

References

    1. AIRC/WHO , “Cancer Today: Cancer Fact Sheets 2022,” 2022, https://gco.iarc.fr/today/fact‐sheets‐cancers.
    1. AIRC/WHO , “Cancer Tomorrow,” https://gco.iarc.fr/tomorrow/en/dataviz/bars?mode=cancer&group_populatio....
    1. AIHW , “Cancer Summary Data Visualisation: Cancer Data in Australia,” https://www.aihw.gov.au/reports/cancer/cancer‐data‐in‐australia/contents....
    1. Loud J. T. and Murphy J., “Cancer Screening and Early Detection in the 21(St) Century,” Seminars in Oncology Nursing 33 (2017): 121–128. - PMC - PubMed
    1. Lin L., Li Z., Yan L., Liu Y., Yang H., and Li H., “Global, Regional, and National Cancer Incidence and Death for 29 Cancer Groups in 2019 and Trends Analysis of the Global Cancer Burden, 1990‐2019,” Journal of Hematology & Oncology 14 (2021): 197. - PMC - PubMed